January 12, 2017
Mainstay Medical to sell its back pain device in Australia
Mainstay Medical International has applied for ReActiv8 to be admitted to the Australian Register of Therapeutic Goods (ARTG) which would…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
January 12, 2017
Pixium Vision completes 10 implants in its Iris II study
Pixium Vision, a company developing and commercializing innovative bionic vision systems, has completed 10 implants in its Iris II study.
January 12, 2017
Trump says “pharma getting away with murder,” stocks slide
U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are “getting away with murder” in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower.
January 12, 2017
Walloon (Belgium) government funds ASIT Biotech’s food allergies treatment research
The Walloon (Belgium) government has decided to fund its ASIT Biotech to help develop new drug candidates to treat the main food allergies caused by peanuts, cow’s milk and egg whites.
January 12, 2017
OptiBiotix with two abstracts at Berlin’s conference ProBiota
OptiBiotix Health will have its two abstracts presented at ProBiota 2017 in Berlin, which is taking place from February 1-3, 2017. ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiota focused food and pharma industries.
January 12, 2017
Mereo’s COO and CFO Richard Bugay joins Diurnal as CFO, UK drugmakers shuffle managers
Two UK-based biopharma companies, Mereo BioPharma and Diurnal have reshuffled their managerial lineups by swapping managers and welcoming new people.
January 12, 2017
MaxCyte’s in Demonstrates CRISPR-Cas9 X-linked CGD gene repair study
MaxCyte has been engaged in a study with National Institutes of Health’s (NIH) allergy and infection section to show certain CYBB gene behaviour in patients with X-linked chronic granulomatous disease (X-CGD).
January 12, 2017
Ablynx starts Phase IIb RESPIRE study of RSV infections treatment
Ablynx has dosed the first patient in the Phase IIb “RESPIRE” dose-ranging efficacy study of ALX-0171, its novel inhaled drug…
January 12, 2017
FDA warns about cancer drug
The Food and Drug Administration is warning consumers not to purchase or use PNC-27, a product promoted and sold through http://PNC27.com,…
January 12, 2017
Celyad: First pancreatic cancer patient in its CAR-T NKR-2THINK trial in Belgium
Celyad has activated a second clinical site in Belgium for the , with the registration of a pancreatic cancer patient…